Therapy Areas: Vaccines
21 February 2024 - Clinical-stage immunotherapy firm ImmunityBio (NASDAQ: IBRX), completes accrual of the first two phases of a national trial assessing its Nant Cancer Vaccine (NCV) in participants w...
19 February 2024 - AstraZeneca (LSE: AZN) (STO: AZN) (Nasdaq: AZN), a science-led biopharmaceutical company, announced on Monday that it has successfully concluded the acquisition of Icosavax Inc, a U...
19 February 2024 - Norway-based clinical-stage biotechnology company Ultimovacs (OSE:ULTI) announced on Monday that it has secured Orphan Drug Designation (ODD) from the European Medicines Agency (EMA...
19 February 2024 - Everest Medicines (HKEX 1952.HK), a China-based biopharmaceutical company, announced on Sunday that it is terminating the collaboration and license agreements with Providence Therap...
14 February 2024 - Biopharmaceutical company VBI Vaccines Inc (Nasdaq: VBIV) announced on Wednesday that it has entered into agreements with Brii Biosciences (Brii Bio) for the sale of manufacturing c...
6 February 2024 - Animal health company ECO Animal Health Group (ECO) (AIM: EAH) announced on Tuesday the approval of the ECOVAXXIN trademark by the European Union (EU). This trademark, also registere...